Dovato is a prescription medication used to treat HIV-1 infection in adults and pediatric patients weighing at least 40 kg. It is a fixed-dose combination tablet containing two active ingredients: dolutegravir and lamivudine. Dolutegravir belongs to a class of drugs known as integrase inhibitors, while lamivudine is a nucleoside reverse transcriptase inhibitor.

This combination medication works by preventing the virus from multiplying and spreading in the body. It is important to take Dovato exactly as prescribed by your healthcare provider to ensure its effectiveness. Missing doses or not following the prescribed regimen can lead to the development of drug-resistant strains of HIV.

Before starting Dovato, it is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have. Some medications may interact with Dovato, potentially reducing its effectiveness or increasing the risk of side effects.

Common side effects of Dovato may include headache, diarrhea, nausea, and fatigue. These side effects are usually mild and temporary, but if they persist or worsen, it is important to contact your healthcare provider.

It is important to continue taking Dovato as prescribed, even if you feel well. HIV treatment is most effective when taken consistently and as directed. Regular monitoring by your healthcare provider is also important to ensure the medication is working properly and to detect any potential side effects early.

Overall, Dovato is a valuable treatment option for individuals living with HIV-1 infection. If you have any questions or concerns about this medication, do not hesitate to speak with your healthcare provider.